Gene Query: EDC3

Dataset Description Geneva Score
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 47.0
Genome-wide functional assessment of enhancer activities in the human genome 37.28
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 32.99
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 31.11
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 24.73
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 24.73
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 19.19
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 18.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 18.99
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 18.77
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 16.79
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 16.79
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 15.88
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 15.25
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 14.49
Genome wide expression change by RNF168 knocking down in MCF-7 cells 14.0
Gene expression changes after LOC550643 silencing 12.92
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 12.81
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 12.54
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 12.26
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 11.77
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.11
RNA-seq analysis of BAP1-depleted uveal melanoma cells 10.77
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.64
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 10.44
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.4
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.34
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.99
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.99
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 9.97
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 9.97
Tracing Enhancer Networks using Epigenetic Traits (TENET) 9.91
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.4
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.4
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.04
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.04
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 8.27
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 8.23
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.2
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.2
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.05
NHLRC1 re-expression in cancer cells 7.96
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.92
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.9
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.87
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 7.77
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 7.77
An integrative analysis of non-coding regulatory DNA variations associated with autism 7.48
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 7.45
Identification of global regulators of T-helper cell lineage specification 7.45
Genome wide expression change by RNF168 knocking down in NEC cells 7.38
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 7.34
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 7.29
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 7.26
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.09
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.07
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.07
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 7.06
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.03
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.89
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.85
DART-seq: an antibody-free method for global m6A detection 6.69
Tracking of dCas9-methyltransferase footprints 6.5
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.46
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.46
Characterization of parental and rociletinib-resistant derived H1975 cell lines 6.43
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 6.31
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 6.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.31
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.29
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.27
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.26
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.26
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.25
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.1
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.09
RNA expression following TMPRSS11B overexpression or depletion 6.07
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.81
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.69
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.64
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.62
T47D RNA-seq and ChrRNA-seq data 5.61
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.61
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.56
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 5.5
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.42
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.42
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.42
RNA transcriptome analysis during HSV-1 infection 5.37
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.36
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.31
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 5.31
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.26
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 5.17
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 5.17
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.14
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.14
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.13
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.09
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 5.09
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.08
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 5.02
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 5.02
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.99
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.99
High-throughput sequencing of pluripotent cells 4.98
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.86
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.81
RNA-seq differential expression studies: more sequence, or more replication? 4.79
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 4.78
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 4.77
RNA-seq in transgenic cells 4.72
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 4.55
The interplay between SOX4 and SMAD3 in the context of breast cancer 4.54
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 4.54
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.54
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.52
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 4.48
Genes significantly down or Up-regulated upon RNF219 knockdown 4.47
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.46
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.46
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 4.43
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 4.42
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.41
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.41
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 4.39
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.39
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 4.38
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 4.38
Knockdown of ADNP in HCT116 colon cancer cells 4.34
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.34
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.32
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.31
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.3
Impact of dieldrin on transcription in Jurkat T cells 4.27
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.27
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 4.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 4.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 4.26
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 4.24
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.21
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.21
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.19
PTHrP overexpression in MCF7 cells 4.19
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.14
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.14
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.1
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 4.1
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.07
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.06
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.04
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.03
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.03
Regulation of poly(A) tail and translation during the somatic cell cycle 4.03
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.01
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.0
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.0
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 3.99
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 3.99
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.99
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.99
Transcriptomic analysis of the HOTAIR-regulated genes 3.98
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 3.97
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.96
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.93
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 3.92
Global epigenomic reconfiguration during mammalian brain development 3.9
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 3.89
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 3.87
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.84
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.83
Differential analysis of gene regulation at transcript resolution by RNA-Seq 3.82
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 3.82
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.82
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.8
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.77
Functional role of CPPED1 in trophoblasts. 3.76
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 3.74
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.73
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.71
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 3.71
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 3.71
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 3.71
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.7
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.7
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.69
The Human Testis Cell Atlas via Single-cell RNA-seq 3.64
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.63
UBC9 knockdown in bladder cancer T24 cell lines 3.63
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 3.62
CD73 knockdown effect in pancreatic cancer cell lines 3.61
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 3.6
Gene expression changes caused by KRAS in MCF-10A 3.59
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 3.57
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 3.57
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.57
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.56
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 3.56
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.56
Cleavage Factor Im as a key regulator of 3’ UTR length 3.55
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.53
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.52
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 3.5
Gene expression in GBM with Cav3.2 inhibition 3.48
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 3.47
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 3.47
hTERT promotes cell adhesion and migration independent of telomerase activity 3.46
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.45
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.44
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 3.43
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.43
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.42
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.41
Global analysis of alternative splicing regulated by RBM10 3.41
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.39
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 3.37
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.37
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.37
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.36
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.34
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.3
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.3
hnRNP C is a key regulator of protein synthesis in mitosis 3.3
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.27
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.27
Differential gene expression of human melanoma cells [RNA-seq] 3.27
Downregulation of DDX5/DDX17 and REST 3.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.25
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.24
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.23
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 3.21
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.18
Biological effect of chronic mistranslation in mammalian cells 3.14
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.13
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.12
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.11
CD86 regulates a pro-survival signal in myeloma cells 3.09
3’ Uridylation Expands miRNA Target Repertoire 3.08
HEK293 TFAM Knockout Expression Study 3.07
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.04
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.04
RNA-seq analysis of differentiating human erythroblasts 3.03
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.02
Seletive inhibition of CDK9 in DLBCL cell lines 2.99
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.99
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 2.97
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.96
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.96
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.93
NR2F2 study 2.93
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.91
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.91
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 2.89
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.88
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.83
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.82
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.82
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.79
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.76
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.74
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.74
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.74
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.73
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.7
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.7
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.67
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.67
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.66
TT-Seq captures the human transient transcriptome 2.64
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.63
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.63
Hepatitis C virus functionally sequesters miR-122 2.63
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.62
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.59
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.58
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.58
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.56
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.54
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.54
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.49
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.48
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.47
Effect of PBK knockdown on C4-2 cell transcriptome 2.47
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.41
METTL3 and WTAP 2.4
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.36
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.33
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.32
Gene expression analysis upon mtDNA depletion 2.32
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.32
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.31
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.27
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.27
Transcriptomic analysis of LSD1 2.27
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.27
RNA-Seq of PRMT1 overexpression ECA109 cells 2.26
Transcriptome sequencing of K-562 cells 2.26
RNA-Seq from human ILC transitional populations 2.26
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.26
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.24
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.24
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.19
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.19
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.18
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.15
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.14
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.14
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.08
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.08
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.08
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.08
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.07
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.06
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.05
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.05
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.03
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.03
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.03
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.02
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.02
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.02
Identification of a LIF-responsive replication-competent human β cell 2.0
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.99
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.98
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.97
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.97
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.96
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.96
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.95
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.87
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.86
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.86
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.78
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.76
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.75
RNA-seq of IL-4 stimulated human keratinocytes 1.75
Comparative Analysis of Cas9 Activators Across Multiple Species 1.73
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 1.73
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.73
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.73
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.71
SNHG5 siRNA knock down in HCT116 cells 1.69
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.69
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.69
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.68
Energy Metabolism during Anchorage-Independence 1.67
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.66
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.64
Activity-dependent transcriptional changes in human neurons 1.63
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.61
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.59
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.57
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.57
Functional significance of the HIV-1 Tat signature amino acid residues 1.56
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.56
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.55
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.54
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.54
miRNAs affected by antagomiR-17 treatment 1.53
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.53
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.53
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.51
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.51
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.48
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.45
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.44
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.42
Iron response of HepG2 cells 1.39
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.38
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.37
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.36
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.35
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.34
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.32
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.31
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.31
mRNA expression in human DAOY cells 1.31
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.3
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.23
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.21
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.19
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.16
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.14
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.14
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.13
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.12
Co-regulation of splicing by Rbfox1 and hnRNP M 1.11
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.11
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.1
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.1
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.09
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.09
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.09
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.08
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.03
O-glcnAc reprograms cellular energetics 1.02
Dermal endothelial cells of type 2 diabetic patients 1.01
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.99
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.99
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.99
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.98
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.98
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.96
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.95
The Genetic Landscape of Diamond-Blackfan Anemia 0.95
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.94
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 0.94
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.93
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.91
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.91
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.91
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.9
Determining mRNA half-lives on a transcriptome-wide scale 0.87
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.87
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.83
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 0.82
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.82
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.81
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.79
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.76
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.76
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.76
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.76
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.75
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.7
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.7
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.69
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.66
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.66
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.65
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.65
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.65
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.61
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.61
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.59
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.59
Transposon-based construction of strand-specific RNA-seq libraries 0.58
Transcriptome-wide modulation of splicing by the exon junction complex 0.57
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.56
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.56
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.56
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.54
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.54
Identification of global XBP1s target gene expression in human prostate cancer cells 0.53
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.51
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.51
Ribosomal protein RPL26 is the principal target of UFMylation 0.5
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.5
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.5
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.49
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.49
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.49
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.46
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.43
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.43
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.42
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.38
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.37
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.37
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.34
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.34
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.31
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.29
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.29
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.29
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.24
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.23
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.23
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.21
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.19
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.19
K562 polyA RNA-Seq 0.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.16
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.14
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.14
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.14
The transcriptome and chromatin accessbility landscape of mammalian germline 0.12
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.11
Role of FGFR1 in neuronal devlopment 0.1
Leucegene: AML sequencing (part 6) 0.09
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.08
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.07
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.07
MHC Transcriptomic landscape at haplotype-specific resolution 0.06
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.06
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.05
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.04
Gene expression profile of CRC-derived HILEC 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation